By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AdvanDx, Inc. 

400 TradeCenter
Suite 6990
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-376-0009 Fax: 781-376-0111



Company News
AdvanDx, Inc. Receives FDA 510(k) Clearance For mecA XpressFISH 11/18/2014 6:16:09 AM
Data From Thirteen Studies Highlighting AdvanDx, Inc.'s Infectious Disease Assays To Be Presented At The 114th General Meeting Of The American Society of Microbiology (ASM) 5/19/2014 6:21:09 AM
AdvanDx, Inc. Raises $12 Million To Accelerate The Expansion Of The Company's Molecular Diagnostic Product Offerings 4/8/2014 8:17:32 AM
AdvanDx, Inc. Announces FDA 510(K) Submission For Meca Xpressfish™ -- A New Method For Rapid Detection Of Methicillin-Resistant Staphylococcus Aureus (MRSA) From Positive Blood Cultures 3/18/2014 10:50:47 AM
AdvanDx, Inc. Adds Gram-Negative BC Assay to U.S. and E.U. Commercial Launch of QuickFISH(TM) - a 20 Min. Pathogen ID Platform for the Identification & Treatment of Sepsis 8/14/2013 9:24:39 AM
AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO, Heiner Dreismann, Ph.D., to Its Board of Directors 3/27/2013 10:58:50 AM
AdvanDx, Inc. Adds Enterococcal Bacteremia Assay to U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID) Platform 1/10/2013 9:12:10 AM
AdvanDx, Inc. Announces U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID), the First Molecular Test to Enable Reporting of Pathogen Identification at the Time of Gram Stain Results From Positive Blood Cultures 9/10/2012 9:29:48 AM
AdvanDx, Inc. to Unveil QuickFISHâ„¢ (20 Min. Pathogen ID) at ECCMID 2012 3/15/2012 10:44:46 AM
AdvanDx, Inc. Release: New Study Shows PNA FISH(R) Test Reporting Dramatically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections 10/13/2011 10:55:05 AM